Hims & Hers Health ($HIMS) Investment Thesis: A Disruptive Force...
Hims & Hers Health (HIMS) emerges as a compelling investment, with a Buy rating and a 12-month price target of $50, suggesting a 45% upside. The company's innovative telehealth platform...